Biden’s Proposed Budget Boosts Investment in Clean Energy Technologies

Mintz took lead role for long-term client NanoView Biosciences in its sale to Unchained Labs, a portfolio company of The Carlyle Group. NanoView, through its ExoView technology, characterizes exosomes and the company’s LentiView platform complements Unchained Labs’ tools for gene therapy researchers working with lentivirus, which is an immunodeficiency virus that causes AIDS.

Investment funds that target companies with ESG policies have experienced record growth. Yet it’s difficult for companies to know which ESG actions will affect the value of their stock. Member O’Kelly McWilliams looks at how creating an ESG infrastructure will help companies capture value as the investment community and market “catch up” with the corporate world’s widespread embrace of ESG.

Mintz Member Suman Chakraborty tells his journey of becoming a recognized first-chair litigator as an LGBTQ+ attorney of color in an article published by the New York Law Journal. 

Mintz's consecutive revenue growth and firm successes for the fiscal 2021 year were recognized in an article published by The American Lawyer. Mintz Managing Member Bob Bodian outlined in the article the growth in revenue, the addition of new Members, and important policies that Mintz put into place this year for its employees. 

A team of two new Members and an Of Counsel with deep patenting capabilities and decades of experience supporting biotech and pharmaceutical clients enhances our already robust Life Sciences IP prosecution and strategy practice.